These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30293653)

  • 21. Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Kaneda K; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Morita Y; Tada T; Chen PM; Murata K; Tsuyuki Y; Nakagawa Y; Nishimoto Y; Saga S; Sakamoto J; Kinoshita M; Togi K; Ishii K; Mabuchi H; Takabayashi K; Hojo S; Kawaji T; Kushiyama A; Yaku H; Nakatsuma K; Kato M; Yokomatsu T; Miki S; Kimura T;
    Thromb Res; 2021 Feb; 198():26-33. PubMed ID: 33264736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
    Squizzato A; Galliazzo S; Rancan E; Di Pilla M; Micucci G; Podda G; Valeriani E; Campiotti L; Bertù L; Ageno W; Porreca E; Lodigiani C
    Intern Emerg Med; 2022 Jan; 17(1):83-90. PubMed ID: 34110563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):262-270. PubMed ID: 30203659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in risk of incident venous thromboembolism in heart failure patients.
    Melgaard L; Nielsen PB; Overvad TF; Skjøth F; Lip GYH; Larsen TB
    Clin Res Cardiol; 2019 Jan; 108(1):101-109. PubMed ID: 30132063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.
    Verso M; Agnelli G; Ageno W; Imberti D; Moia M; Palareti G; Pistelli R; Cantone V;
    Thromb Res; 2012 Sep; 130(3):369-73. PubMed ID: 22583838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
    Chatani R; Yamashita Y; Morimoto T; Mushiake K; Kadota K; Kaneda K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Ogihara Y; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Nishikawa R; Kimura T;
    Thromb Res; 2024 Feb; 234():86-93. PubMed ID: 38190788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
    Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
    Tsuyuki Y; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Kobayashi Y; Ono K; Aoyama T; Kimura T;
    Thromb Res; 2020 Mar; 187():39-47. PubMed ID: 31951937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N
    Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
    Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
    Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Baseline Thrombocytopenia on Late Bleeding and Mortality After Transcatheter Aortic Valve Implantation (From the Japanese Multicenter OCEAN-TAVI Registry).
    Ito S; Taniguchi T; Shirai S; Ando K; Watanabe Y; Yamamoto M; Naganuma T; Takagi K; Yamawaki M; Tada N; Yamanaka F; Tabata M; Ueno H; Yashima F; Hayashida K
    Am J Cardiol; 2021 Feb; 141():86-92. PubMed ID: 33220320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
    Lecumberri R; Ruiz-Artacho P; Trujillo-Santos J; Brenner B; Barillari G; Ruiz-Ruiz J; Lorente MA; Verhamme P; Vázquez FJ; Weinberg I; Monreal M;
    Thromb Res; 2020 Nov; 195():139-145. PubMed ID: 32693201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of venous thromboembolism chemoprophylaxis timing on venous thromboembolism after major vascular surgery.
    Sutzko DC; Georgoff PE; Obi AT; Healy MA; Osborne NH
    J Vasc Surg; 2018 Jan; 67(1):262-271.e1. PubMed ID: 28870681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
    Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.